SCHEMBL2197637

SCHEMBL2197637

CC(=O)N[C@@H](C(=O)N1CCCC1C(=O)Nc1ccc(-c2cnc(-c3ccc(NC(=O)C4CCCN4C(=O)[C@H](NC(C)=O)c4ccccc4)cc3)o2)cc1)c1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.63
CYP2C9 P11712 6/20 0.52
CYP2C19 P33261 6/20 0.52
CYP3A4 P08684 5/20 0.52
CYP2D6 P10635 2/20 0.52
CYP1A2 P05177 2/20 0.52
ALDH1A1 P00352 4/20 0.46
MAPK1 P28482 3/20 0.46
GAA P10253 2/20 0.46
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
NPC1 O15118 1/20 0.46
TP53 P04637 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HSD17B10 Q99714 1/20 0.46
SMO Q99835 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20054635 0.87 KCNH2 (0.55) KCNH2CYP2C9CYP2C19CYP3A4CYP2D6
SCHEMBL2198301 0.87 KCNH2 (0.53) KCNH2CYP2C9CYP2C19CYP3A4CYP2D6
SCHEMBL2195345 0.87 KCNH2 (0.53) KCNH2CYP2C9CYP2C19CYP3A4CYP2D6
SCHEMBL13388242 0.87 KCNH2 (0.81) KCNH2CYP2C9CYP2C19CYP3A4CYP2D6
SCHEMBL12406104 0.86 KCNH2 (0.49) KCNH2CYP2C9CYP2C19CYP3A4CYP2D6
SCHEMBL2284214 0.86 KCNH2 (0.49) KCNH2CYP2C9CYP2C19CYP3A4CYP2D6
SCHEMBL15896296 0.86 KCNH2 (0.49) KCNH2CYP2C9CYP2C19CYP3A4CYP2D6
SCHEMBL12488524 0.86 KCNH2 (0.53) KCNH2CYP2C9CYP2C19CYP3A4CYP2D6
SCHEMBL12490151 0.86 KCNH2 (0.53) KCNH2CYP2C9CYP2C19CYP3A4CYP2D6
SCHEMBL16495777 0.86 KCNH2 (0.52) KCNH2CYP2C9CYP2C19CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362020-B2 Hepatitis C virus inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2013-01-29 US claimed
EP-2519506-A1 HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2012-11-07 EP claimed
WO-2011082077-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2011-07-07 WO claimed